The Pharmacovigilance and Drug Safety Software Market which was valued at USD 6.83 billion in 2022, is projected to grow significantly to USD 14.86 billion by 2030, registering a compound annual growth rate (CAGR) of 10.2% over the forecast period from 2023 to 2030. This robust growth is attributed to the rising importance of monitoring drug safety, increasing...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian